Literature DB >> 34019255

Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention.

Erica Bell1,2,3, Phil Boyce4,5, Richard J Porter6, Richard A Bryant7, Gin S Malhi8,9,10.   

Abstract

Feeling irritable is a common experience, both in health and disease. In the context of psychiatric illnesses, it is a transdiagnostic phenomenon that features across all ages, and often causes significant distress and impairment. In mood disorders, irritability is near ubiquitous and plays a central role in diagnosis and yet, despite its prevalence, it remains poorly understood. A neurobiological model of irritability posits that, in children and adolescents, it is consequent upon deficits in reward and threat processing, involving regions such as the amygdala and frontal cortices. In comparison, in adults with mood disorders, the few studies that have been conducted implicate the amygdala, orbitofrontal cortices, and hypothalamus; however, the patterns of activity in these areas are at variance with the findings in youth. These age-related differences seem to extend to the neurochemistry of irritability, with links between increased monoamine transmission and irritability evident in adults, but aberrant levels of, and responses to, dopamine in youth. Presently, there are no specific treatments that have significant efficacy in reducing irritability in mood disorders. However, treatments that hold some potential and warrant further exploration include agents that act on serotonergic and dopaminergic systems, especially as irritability may serve as a prognostic indicator for overall clinical responsiveness to specific medications. Therefore, for understanding and treatment of irritability to advance meaningfully, it is imperative that an accurate definition and means of measuring irritability are developed. To achieve this, it is necessary that the subjective experience of irritability, both in health and illness, is better understood. These insights will inform an accurate, comprehensive, and valid interrogation of the qualities of irritability in health and illness, and allow not only a clinical appreciation of the phenomenon, but also a deeper understanding of its important role within the development and manifestation of mood disorders.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34019255     DOI: 10.1007/s40263-021-00823-y

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  93 in total

1.  Mental health problems during puberty: Tanner stage-related differences in specific symptoms. The TRAILS study.

Authors:  Albertine J Oldehinkel; Frank C Verhulst; Johan Ormel
Journal:  J Adolesc       Date:  2010-02-21

Review 2.  The developmental psychopathology of irritability.

Authors:  Ellen Leibenluft; Joel Stoddard
Journal:  Dev Psychopathol       Date:  2013-11

3.  Irritability characteristics and parameters in an international sample.

Authors:  Michael J Toohey
Journal:  J Affect Disord       Date:  2019-11-09       Impact factor: 4.839

Review 4.  Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria.

Authors:  Zahinoor Ismail; Jennifer Gatchel; Daniel R Bateman; Ricardo Barcelos-Ferreira; Marc Cantillon; Judith Jaeger; Nancy J Donovan; Moyra E Mortby
Journal:  Int Psychogeriatr       Date:  2017-09-13       Impact factor: 3.878

Review 5.  Irritability in Children and Adolescents.

Authors:  Melissa A Brotman; Katharina Kircanski; Ellen Leibenluft
Journal:  Annu Rev Clin Psychol       Date:  2017-05-08       Impact factor: 18.561

Review 6.  Hormones and mood: from menarche to menopause and beyond.

Authors:  Meir Steiner; Edward Dunn; Leslie Born
Journal:  J Affect Disord       Date:  2003-03       Impact factor: 4.839

7.  Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.

Authors:  Susan D Mayes; James D Waxmonsky; Susan L Calhoun; Edward O Bixler
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-01-08       Impact factor: 2.576

Review 8.  Impact of anabolic androgenic steroids on adolescent males.

Authors:  Augustus R Lumia; Marilyn Y McGinnis
Journal:  Physiol Behav       Date:  2010-01-22

Review 9.  Defining and measuring irritability: Construct clarification and differentiation.

Authors:  Michael J Toohey; Raymond DiGiuseppe
Journal:  Clin Psychol Rev       Date:  2017-02-01

10.  The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication.

Authors:  M Fava; I Hwang; A J Rush; N Sampson; E E Walters; R C Kessler
Journal:  Mol Psychiatry       Date:  2009-03-10       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.